Literature DB >> 1521911

Matrigel promotes retinoblastoma cell growth in vitro and in vivo.

A Albini1, A Melchiori, A Garofalo, D M Noonan, F Basolo, G Taraboletti, G J Chader, R Gavazzi.   

Abstract

Cells derived from retinoblastomas grow slowly in vitro and only very rarely form tumors in nude mice. Matrigel, a mixture of components normally found in basement membranes, promotes the growth of Y-79 and WERI-Rb1 retinoblastoma (Rb) cells when added to suspension cultures of the 2 Rb cell lines. It also substantially increases cell adhesion in vitro. Y-79 cells, seeded into a Matrigel matrix, form round colonies over a 3-week period similar to those of control, weakly metastatic murine melanoma cells. In vivo, s.c. co-injection of Matrigel with either Y-79 or WERI-Rb 1 cells into nude mice promotes retinoblastoma tumor formation. Transplantation of as few as 1,000 cells allows for xenografting under these conditions, while no tumors were observed in the absence of Matrigel, even at 10 x 10(6) cells/inoculum. The tumors produced have the expected morphology and express an mRNA for a highly specific retina/retinoblastoma marker protein, the interphotoreceptor retinoid-binding protein. Thus, the xenografts obtained maintain the original morphological and molecular characteristics of the injected cells and represent a useful model for in vivo studies of retinoblastoma growth and treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521911     DOI: 10.1002/ijc.2910520214

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  13 in total

1.  Characterization of novel clonal murine endothelial cell lines with an extended life span.

Authors:  U Cavallaro; V Castelli; A Perilli; R Dossi; R Giavazzi; M S Pepper; M R Soria; R Montesano
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  Effects of extracellular matrix and neighboring cells on induction of human embryonic stem cells into retinal or retinal pigment epithelial progenitors.

Authors:  Jie Gong; Ofer Sagiv; Hui Cai; Stephen H Tsang; Lucian V Del Priore
Journal:  Exp Eye Res       Date:  2008-03-28       Impact factor: 3.467

3.  Cardiac cell therapy: the next (re)generation.

Authors:  Elvira Forte; Isotta Chimenti; Lucio Barile; Roberto Gaetani; Francesco Angelini; Vittoria Ionta; Elisa Messina; Alessandro Giacomello
Journal:  Stem Cell Rev Rep       Date:  2011-11       Impact factor: 5.739

4.  Clinical improvement and enhanced collateral vessel growth after xenogenic monocyte transplantation.

Authors:  Martin Wagner; Adrian Mahlmann; Elisabeth Deindl; Werner Zuschratter; Monika Riek-Burchardt; Sawa Kostin; Blerim Luani; Claudia Baer; Akram Youssef; Joerg Herold
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

5.  Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro.

Authors:  V Dolo; S D'Ascenzo; S Violini; L Pompucci; C Festuccia; A Ginestra; M L Vittorelli; S Canevari; A Pavan
Journal:  Clin Exp Metastasis       Date:  1999-03       Impact factor: 5.150

6.  From passive diffusion to active cellular migration in mathematical models of tumour invasion.

Authors:  P Tracqui
Journal:  Acta Biotheor       Date:  1995-12       Impact factor: 1.774

7.  Neferine induces mitochondrial dysfunction to exert anti-proliferative and anti-invasive activities on retinoblastoma.

Authors:  Jing Wang; Yanmin Dong; Qiuming Li
Journal:  Exp Biol Med (Maywood)       Date:  2020-05-28

Review 8.  Injectable materials for the treatment of myocardial infarction and heart failure: the promise of decellularized matrices.

Authors:  Jennifer M Singelyn; Karen L Christman
Journal:  J Cardiovasc Transl Res       Date:  2010-07-15       Impact factor: 4.132

9.  Variant sublines of early-stage human melanomas selected for tumorigenicity in nude mice express a multicytokine-resistant phenotype.

Authors:  H Kobayashi; S Man; J R MacDougall; C H Graham; C Lu; R S Kerbel
Journal:  Am J Pathol       Date:  1994-04       Impact factor: 4.307

Review 10.  Minimally invasive cell-seeded biomaterial systems for injectable/epicardial implantation in ischemic heart disease.

Authors:  Rajeswari Ravichandran; Jayarama Reddy Venugopal; Subramanian Sundarrajan; Shayanti Mukherjee; Seeram Ramakrishna
Journal:  Int J Nanomedicine       Date:  2012-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.